[Hormone substitution following transcervical endometrial ablation]

The transcervical endometrium ablation is more and more used for the treatment of therapy refractory bleeding disorders. Since in 70% of the patients, even with a postoperative amenorrhoea, a residual endometrium can be found a hormone replacement therapy should in any case include a sequential or continuous application of progestagen. For the prevention of a hematometra by using a hormone replacement therapy the cervix should be spared during endometrium ablation. With recurrent therapy-refractory bleeding disorders during hormone replacement therapy an indication for endometrium ablation can also be given. In these patients a postoperative amenorrhoea can be reached by a continuous hormone replacement therapy.